{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:58:21Z","timestamp":1761515901221,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.4158\/ep12269.or","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T21:03:25Z","timestamp":1358802205000},"page":"462-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of Baseline Glycosylated Hemoglobin A1C on Glycemic Control and Diabetes Management following Initiation of Once-daily Insulin Detemir in Real-Life Clinical Practice"],"prefix":"10.1016","volume":"19","author":[{"given":"Salvatore","family":"Caputo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddy","family":"Karnieli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi F.","family":"Meneghini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Louise Svendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP12269.OR_bb0010","first-page":"455","article-title":"Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study","volume":"57","author":"Calvert","year":"2007","journal-title":"Br J Gen Pract"},{"key":"10.4158\/EP12269.OR_bb0015","first-page":"S4","article-title":"Insulin therapy and quality of life. A review","volume":"25(Suppl 1)","author":"Pouwer","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.4158\/EP12269.OR_bb0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12269.OR_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3810\/pgm.2011.07.2301","article-title":"Basal insulin: beyond glycemia","volume":"123","author":"Niswender","year":"2011","journal-title":"Postgrad Med"},{"key":"10.4158\/EP12269.OR_bb0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/dc09-1184","article-title":"Barriers to insulin initiaton: the translating research into action starts project","volume":"33","author":"Karter","year":"2010","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12269.OR_bb0035","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12269.OR_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5694\/j.1326-5377.2006.tb00264.x","article-title":"Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study","volume":"184","author":"Davis","year":"2006","journal-title":"Med J Aust"},{"key":"10.4158\/EP12269.OR_bb0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4158\/EP.13.3.260","article-title":"Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE\/AACE Diabetes Road Map Task Force","volume":"13","author":"Jellinger","year":"2007","journal-title":"Endocr Pract"},{"key":"10.4158\/EP12269.OR_bb0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4065\/mcp.2010.0434","article-title":"Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus","volume":"86","author":"O\u2019Keefe","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.4158\/EP12269.OR_bb0055","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4158\/EP.15.6.540","article-title":"Statement by an American Association of Clinical Endocrinologists\/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control","volume":"15","author":"Rodbard","year":"2009","journal-title":"Endocr Pract"},{"journal-title":"Royal College of Physicians","article-title":"Type 2 Diabetes - full guideline","year":"2008","key":"10.4158\/EP12269.OR_bb0060"},{"journal-title":"Royal College of Physicians","article-title":"Type 2 diabetes - newer agents","year":"2009","key":"10.4158\/EP12269.OR_bb0065"},{"key":"10.4158\/EP12269.OR_bb0070","first-page":"e418","article-title":"Clinical inertia in patients with T2DM requiring insulin in family practice","volume":"56","author":"Harris","year":"2010","journal-title":"Can Fam Physician"},{"key":"10.4158\/EP12269.OR_bb0075","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"10.4158\/EP12269.OR_bb0080","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00125-009-1352-5","article-title":"Megatrials in type 2 diabetes. From excitement to frustration?","volume":"52","author":"Del Prato","year":"2009","journal-title":"Diabetologia"},{"key":"10.4158\/EP12269.OR_bb0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"10.4158\/EP12269.OR_bb0090","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2337\/dc06-1120","article-title":"Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis","volume":"29","author":"Bloomgarden","year":"2006","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12269.OR_bb0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1464-5491.2010.02941.x","article-title":"Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials","volume":"27","author":"DeFronzo","year":"2010","journal-title":"Diabet Med"},{"key":"10.4158\/EP12269.OR_bb0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1742-1241.2010.02619.x","article-title":"Relationship of baseline HbA1c, HbA1c change and HbA1c target of <7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"65","author":"Giugliano","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.4158\/EP12269.OR_bb0105","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2337\/dc09-1727","article-title":"The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis","volume":"33","author":"Sherifali","year":"2010","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12269.OR_bb0110","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1185\/03007995.2011.555755","article-title":"Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries","volume":"27","author":"Liebl","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.4158\/EP12269.OR_bb0115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1463-1326.2012.01602.x","article-title":"Study of once-daily levemir (SOLVETM): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice","volume":"14","author":"Khunti","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP12269.OR_bb0120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1185\/03007990902739669","article-title":"Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study","volume":"25","author":"Jones","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.4158\/EP12269.OR_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1463-1326.2008.00881.x","article-title":"Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study","volume":"10(Suppl 1)","author":"Alvarez Guisasola","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP12269.OR_bb0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.4158\/EP12269.OR_bb0135","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12269.OR_bb0140","doi-asserted-by":"crossref","first-page":"854","DOI":"10.7326\/0003-4819-151-12-200912150-00005","article-title":"Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study","volume":"151","author":"Greenfield","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP12269.OR_bb0145","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12269.OR_bb0150","doi-asserted-by":"crossref","first-page":"b4909","DOI":"10.1136\/bmj.b4909","article-title":"The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study","volume":"340","author":"Bonds","year":"2010","journal-title":"BMJ"},{"key":"10.4158\/EP12269.OR_bb0155","doi-asserted-by":"crossref","first-page":"b5444","DOI":"10.1136\/bmj.b5444","article-title":"The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study","volume":"340","author":"Miller","year":"2010","journal-title":"BMJ"},{"key":"10.4158\/EP12269.OR_bb0160","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2011-1074","article-title":"Weight beneficial treatments for type 2 diabetes","volume":"96","author":"Meneghini","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12269.OR_bb0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1463-1326.2006.00665.x","article-title":"Does insulin detemir have a role in reducing risk of insulin-associated weight gain?","volume":"9","author":"Hermansen","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP12269.OR_bb0170","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2165\/11470200-000000000-00000","article-title":"Insulin detemir: a review of its use in the management of diabetes mellitus","volume":"72","author":"Keating","year":"2012","journal-title":"Drugs"},{"key":"10.4158\/EP12269.OR_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4158\/EP.12.2.145","article-title":"Glycemic relapse in type 2 diabetes","volume":"12","author":"Graber","year":"2006","journal-title":"Endocr Pract"},{"key":"10.4158\/EP12269.OR_bb0180","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/dc11-1171","article-title":"Glycemic response and attainment of A1C goals following newly initiated insulin therapy for type 2 diabetes","volume":"35","author":"Nichols","year":"2012","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12269.OR_bb0185","doi-asserted-by":"crossref","first-page":"E1579","DOI":"10.1210\/jc.2012-2043","article-title":"Health disparities in endocrine disorders: biological, clinical, and nonclinical factors-an Endocrine Society scientific statement","volume":"97","author":"Golden","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/X20795477N5760P8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:55:14Z","timestamp":1761515714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20421482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1530891X20421482"],"URL":"https:\/\/doi.org\/10.4158\/ep12269.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Baseline Glycosylated Hemoglobin A1C on Glycemic Control and Diabetes Management following Initiation of Once-daily Insulin Detemir in Real-Life Clinical Practice","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12269.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}